In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Predictive Biosciences Inc.

www.predictivebiosci.com

Latest From Predictive Biosciences Inc.

Molecular Dx Labs’ Concerns Shift To Coverage Issues With Release Of Interim Medicare Payment Amounts

Now that CMS has posted the interim payment amounts for more than 100 new molecular pathology codes, industry is concerned whether the tests will be covered at all.

Medical Device Reimbursement

Molecular Dx Labs Fret Over Medicare Payment Setting, Or, In Some Cases, Lack Thereof

The industry’s angst is growing several months after CMS announced a plan to task contractors with independently setting regional payments for more than 100 new molecular diagnostic codes. A breakdown in the process so far, stakeholders say, could have a lasting impact on small, venture-backed labs.

Medical Device Reimbursement

On The Move: Who’s Going Where In Biopharma And Medtech Start-Ups

Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.

Start-Up Quarterly Statistics, Q4 2010

Biopharma, medical device and in vitro diagnostics start-ups brought in a total of $548 million in Q4 2010, a 30% drop from the previous quarter and a 24% decrease from Q4 2009. Six start-up acquisitions were completed - five in the biopharmaceutical industry and one diagnostic transaction. In the fourth quarter there were 27 start-up biopharma alliances covering a wide range of therapeutic categories, and fourteen of them involved large molecules.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
    • Urine-based Testing
  • Laboratory Testing Services
    • Anatomical Pathology
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Predictive Biosciences Inc.
  • Senior Management
  • Pierre Cassigneul, Pres. & CEO
    Vikram Lamba, CFO & CBO
    Angelo M De Marzo, MD, PhD, CMO
  • Contact Info
  • Predictive Biosciences Inc.
    Phone: (781) 402-1780
    128 Spring St., 400 Level
    B Annex
    Lexington, MA 02421
    USA
UsernamePublicRestriction

Register